Article
Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development.
Faculty of Dentistry, The University of Hong Kong, Oral Biosciences, 5/F, Prince Phillip Dental Hospital, 34, Hospital Road, Sai Ying Pun, Hong Kong.
BMC Microbiology (impact factor:
3.04).
04/2010;
10:125.
DOI:10.1186/1471-2180-10-125
pp.125
Source: PubMed
-
Citations (0)
- Cited In (2)
-
Article: Candida biofilms and the host: models and new concepts for eradication.
[show abstract] [hide abstract]
ABSTRACT: Biofilms define mono- or multispecies communities embedded in a self-produced protective matrix, which is strongly attached to surfaces. They often are considered a general threat not only in industry but also in medicine. They constitute a permanent source of contamination, and they can disturb the proper usage of the material onto which they develop. This paper relates to some of the most recent approaches that have been elaborated to eradicate Candida biofilms, based on the vast effort put in ever-improving models of biofilm formation in vitro and in vivo, including novel flow systems, high-throughput techniques and mucosal models. Mixed biofilms, sustaining antagonist or beneficial cooperation between species, and their interplay with the host immune system are also prevalent topics. Alternative strategies against biofilms include the lock therapy and immunotherapy approaches, and material coating and improvements. The host-biofilm interactions are also discussed, together with their potential applications in Candida biofilm elimination.International Journal of Microbiology 01/2012; 2012:845352. -
Article: The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.
[show abstract] [hide abstract]
ABSTRACT: Given the polymicrobial nature of pulmonary infections in patients with cystic fibrosis (CF), it is essential to enhance our knowledge on the composition of the microbial community to improve patient management. In this study, we developed a pyrosequencing approach to extensively explore the diversity and dynamics of fungal and prokaryotic populations in CF lower airways. Fungi and bacteria diversity in eight sputum samples collected from four adult CF patients was investigated using conventional microbiological culturing and high-throughput pyrosequencing approach targeting the ITS2 locus and the 16S rDNA gene. The unveiled microbial community structure was compared to the clinical profile of the CF patients. Pyrosequencing confirmed recently reported bacterial diversity and observed complex fungal communities, in which more than 60% of the species or genera were not detected by cultures. Strikingly, the diversity and species richness of fungal and bacterial communities was significantly lower in patients with decreased lung function and poor clinical status. Values of Chao1 richness estimator were statistically correlated with values of the Shwachman-Kulczycki score, body mass index, forced vital capacity, and forced expiratory volume in 1 s (p = 0.046, 0.047, 0.004, and 0.001, respectively for fungal Chao1 indices, and p = 0.010, 0.047, 0.002, and 0.0003, respectively for bacterial Chao1 values). Phylogenetic analysis showed high molecular diversities at the sub-species level for the main fungal and bacterial taxa identified in the present study. Anaerobes were isolated with Pseudomonas aeruginosa, which was more likely to be observed in association with Candida albicans than with Aspergillus fumigatus. In light of the recent concept of CF lung microbiota, we viewed the microbial community as a unique pathogenic entity. We thus interpreted our results to highlight the potential interactions between microorganisms and the role of fungi in the context of improving survival in CF.PLoS ONE 01/2012; 7(4):e36313. · 4.09 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
bacterial-fungal interactions
biofilm development
C. glabrata
C. parapsilosis
Candida P
different species
dual species biofilm
dual species biofilm development
dual species environment
interspecies interactions
mixed species biofilms
molecular basis
monospecies counterparts
P. aeruginosa
P. aeruginosa numbers
P. aeruginosa numbers co-cultured
P. aeruginosa P
Pseudomonas aeruginosa
significant mutual inhibition
understanding infectious diseases